Loading clinical trials...
Loading clinical trials...
Botulism Antitoxin Effects on Paralysis Induced by Type A and Type B Botulinum Neurotoxins in the Extensor Digitorum Brevis Muscle
Conditions
Interventions
Botulism Antitoxin Bivalent (Equine) Types A and B
Botulism Antitoxin Heptavalent (Equine) Types A-G
Locations
2
United States
Dr. Gordon Peterson
Loma Linda, California, United States
R. Richard Sloop, M. D.
Yakima, Washington, United States
Start Date
February 1, 2008
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
March 18, 2024
NCT07310264
NCT06342713
NCT07472361
NCT06649110
NCT06823947
NCT07240675
Lead Sponsor
Emergent BioSolutions
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions